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Abstract
The Ac ¸aı ´ (Acai) fruit is a popular nutritional supplement that purportedly enhances immune system function. These
anecdotal claims are supported by limited studies describing immune responses to the Acai polyphenol fraction. Previously,
we characterized cd T cell responses to both polyphenol and polysaccharide fractions from several plant-derived nutritional
supplements. Similar polyphenol and polysaccharide fractions are found in Acai fruit. Thus, we hypothesized that one or
both of these fractions could activate cd T cells. Contrary to previous reports, we did not identify agonist activity in the
polyphenol fraction; however, the Acai polysaccharide fraction induced robust cd T cell stimulatory activity in human,
mouse, and bovine PBMC cultures. To characterize the immune response to Acai polysaccharides, we fractionated the crude
polysaccharide preparation and tested these fractions for activity in human PBMC cultures. The largest Acai polysaccharides
were the most active in vitro as indicated by activation of myeloid and cd T cells. When delivered in vivo, Acai polysaccharide
induced myeloid cell recruitment and IL-12 production. These results define innate immune responses induced by the
polysaccharide component of Acai and have implications for the treatment of asthma and infectious disease.
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Introduction
Herbal products have been used in traditional medicines for a
variety of infectious and inflammatory diseases. Many of these
plant materials enhance the activity of cells of the innate immune
system and modify host responses [1–5]. Though their use is
widespread, in many instances the details of these immune
responses are unknown and the optimal therapeutic potential of
these materials is unrealized. Most studies describing the innate
immune response to herbal products focus on cells of the myeloid
lineage, such as macrophages and neutrophils. Our studies
incorporate an additional cell type, the cd T cell, which responds
to at least three distinct herbal components [1,3,6]. cd T cells are
well placed to respond to traditional medicines as they are found in
the intestinal mucosa and virtually all portals of entry in the body.
These T cells contribute to effective innate immune responses
against a variety of infectious agents [7–11]. They also facilitate
downstream adaptive immune responses, due in part to cytokine
production [12–14] and stimulation of dendritic cell function
[15,16]. cd T cells are also potent cytolytic cells [17,18], can
present antigen [19,20], induce or suppress inflammation [21–23],
and are important to the health of epithelial cell monolayers
[24,25]. Due to the abundance of functional responses elicited by
this cell type, its role in response to traditional medicine may have
clinical relevance. In fact, novel therapeutic protocols, developed
from natural agonists for the cd T cell, are being pursued in the
clinic to combat infection and cancers [26,27].
The consumption of some traditional medicines is associated
with the induction of cd T cell activity. For example, the health
benefits of tea consumption can be linked to stimulation of the
human cd T cell anti-microbial response [28,29]. Additionally,
some fruit and vegetable juices expand cd T cells following
consumption [30,31]. Recently, we elaborated upon this associ-
ation between traditional medicines and cd T cell activity by
defining immunomodulatory components within common tradi-
tional medicines.
Thusfar,three functionallyandstructurallydistinct plant-derived
agonists capable of inducing cd T cell responses are described:
prenyl phosphates, polyphenols, and polysaccharides. Prenyl
phosphates derived from plant and microbial sources [6,32] rapidly
expand a subset of human cd T cells, but function only in primate
species. The polyphenol agonists act directly on the cd T cell, and
other cell types, by inducing a priming response, typified by up-
regulation of activation markers and an increased responsiveness to
secondary stimuli [1]. While cd T cell activating polyphenols are
found in several plants [3], the polyphenol agonists are best
illustrated with non-ripeapplepeelpolyphenols(APP) [1]. The most
active polyphenol fraction identified consists of oligomeric procya-
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B contain agonist activity [33 and unpublished observations],
suggesting polyphenol agonists are structurally heterogeneous. The
final type of plant product with cd T cell agonist activity includes
polysaccharides from Yamoa
TM, the ground bark of the Funtumia
elastica tree [1,2]. Yamoa
TM polysaccharides (referred to herein as
Yam-1) induce in vitro effects on cd T cells from bovine calves,
humans, and mice. While cd T cells respond directly to Yamoa
polysaccharides, these responses are greatly amplified during
monocyte/macrophage co-culture [2]. As a limitation to our
understanding its activity, Yamoa
TM exhibits reactivity in the
limulus amebocyte lysate (LAL) assay. For this reason, separating
polysaccharide agonist activity from the endotoxin activity in this
preparation is problematic. Nonetheless, there is apparently an
endotoxin-independent component of Yamoa
TM as evidenced by a
retained response in MyD88
2/2 and TLR4
2/2 mice [2].
The fruit from Acai, Euterpe oleracea, has become a popular
nutritional supplement with anecdotal claims in support of
immune stimulation. Since Acai contains both polyphenols and
polysaccharides, it was tested for cd T cell agonist activity.
Whereas others have reported that the major polyphenol
components from Acai contain immunomodulatory functions
[34–38], we found that the polysaccharides, and not the
polyphenols, from Acai stimulated bovine, mouse and human cd
T cells in mixed leukocyte cultures. Acai-derived polysaccharides
also stimulated monocytes/macrophages, which was not due to
endotoxin contamination, since the Acai fractions were found to
contain very low LAL activity and were similarly active after
polymyxin B treatment to remove residual endotoxin. Moreover,
we evaluated proinflammatory responses to Acai polysaccharides
in vivo; after either intraperitoneal or intratracheal administration
of Acai polysaccharides, neutrophil recruitment to the respective
tissue was observed. Furthermore, delivery of Acai polysaccharides
to the lung activated alveolar macrophages and induced IL-12
production. Overall, these results indicate that the polysaccharide
fraction is responsible, at least in part, for the immune responses
reported for Acai and underscore its potential use as a therapeutic
or prophylactic treatment for infectious disease.
Materials and Methods
Ethics Statement
All animal experiments were performed in accordance with
National Institutes of Health guidelines and approved by the
Institutional Animal Care and Use Committee (protocol identifi-
cation: 2008-15, 2009-3). Human subjects testing was performed
in accord with the Institutional Review Board of Montana State
University (approval identification: MJ032609) and written,
informed consent was obtained from all individuals.
2.1. Animals
TLR4
2/2 and TCRa
2/2 mice (both on the C57BL/6
background) as well as C3H-HeJ and C3H-HeOuJ mice used in
this study were originally obtained from Jackson Laboratories (Bar
Harbor, ME). MyD88
2/2 mice were kindly provided by Dr.
Kieren A. Marr. All mice were housed and bred at the Animal
Resource Center at Montana State University.
One to four month-old bull Holstein calves used in this study
were housed at the large animal facility of Montana State
University.
2.2. Polysaccharide isolation from Acai
Acai fruit pulp was obtained from two sources: Acai 100
(Genesis Today; Austin, TX) and Acai Berry Pure (Acai Berry
Pure Bulk; Carlsbad, CA). The Acai 100 preparation consisted of
100% pure, liquid-format Acai fruit and was used to obtain
preliminary results (data not shown) as well as to prepare the
preliminary EtOH precipitation and Kupchan fractionation [39]
products assayed in Figure 1A (prepared by contract: PhytoMyco
Research Corporation; Greenville, North Carolina).
All other experiments utilized Acai Berry Pure. Polysaccharides
were isolated from this powdered Acai as described previously for
other polysaccharides[2]. Briefly, 1500 g of Acai powder was
extracted with 8 L boiling distilled H2O for 1 h. The aqueous
extract was then centrifuged at 2,000 x g for 15 min, and a 4-fold
volume of ethanol was added to the supernatant to precipitate
p o l y s a c c h a r i d e so v e r n i g h ta t4 uC .T h ep r e c i p i t a t ew a sp e l l e t e db y
centrifugation, re-dissolved in distilled H2O, and centrifuged at
2,000 x g for 15 min. The supernatant fluid (crude polysaccharide
extract) was fractionated using ion-exchange chromatography on a
DEAE-cellulose column equilibrated with 0.05 M Tris-HCl buffer
(pH 8.0). Bound material was sequentially eluted with 0.05 M Tris-
HClbufferand2 MNaCl;arecoveryof0.27%byweightor4 gtotal
weight was achieved. The presence of polysaccharides in the
unbound fraction, eluted with 0.05 M Tris-HCl buffer was minimal
(,0.1% of total bound fraction). The Acai-PS fraction was generated
from the bound material after concentration in an Amicon
concentrator with a 10 kDa Amicon PM10 membrane (Millipore;
Billerica, MA). Further fractions were produced by size exclusion
chromatography on a Sepharose-6B column (2.5695 cm) equilibrat-
ed with 0.01 M Tris-HCl buffer (pH 7.2) containing 0.15 M NaCl
and eluted with the same buffer at a flow rate of 22 mL/h. The
relevant fractions were pooled and concentrated. Three fractions
were obtained, designated as Acai-1 (0.7 g total weight), Acai-2 (1.5 g
total weight), and Acai-3 (0.85 g total weight). These fractions were
analyzed by HPLC, and elution was monitored with a refractive
index detector as described previously [40].
2.3. Polyphenol isolation and removal
Acai polyphenols were extracted from dried fruit pulp using the
method described by Rodrigues et al [38]. Briefly, 100 g of Acai
fruit (Acai Berry Pure) was washed over a three day period with
exchanges of 350 mL, 350 mL, and 300 mL of MeOH. Next, the
MeOH-extracted material was dried using a Savant SpeedVacH
Plus SC210A Concentrator (Thermo Scientific; Waltham, MA).
To isolate polyphenols, 5 g of polyvinylpolypyrrolidone (PVPP;
Sigma-Aldrich, St. Louis, MO), triple-washed in water, was added
to 5 mL of 24 mg/mL water-reconstituted, MeOH-extracted
Acai. Polyphenols were allowed to adsorb to the PVPP matrix for
10 min prior to triple-washing with 20 mL DPBS. Polyphenols
were eluted with 10 mL of 0.5 N NaOH for 5 min. The resulting
polyphenols were adjusted to approximately pH 7.0 with HCl,
dried to determine weight, and tested for their ability to stimulate
human peripheral blood mononuclear cells (PBMCs).
For a second approach to measure polyphenol contribution,
Acai-PS (100 mg) was transferred over a column containing 2 g of
triple-washed PVPP. The eluent was filtered through a 0.2 mm
filter and similarly assessed for stimulatory activity.
2.4. Characterization of Acai-PS fractions
The presence of type II arabinogalactan structures was detected
by single radial diffusion in a 1% agarose gel containing 0.1 mg/
mL b-glucosyl-Yariv reagent (4-b-d-glucopyranosyl oxyphenylazo-
2,4,6-trihydroxybenzene [Biosupplies; Melbourne, Australia])
which specifically interacts with and precipitates compounds
containing type II arabinogalactan structures. A solution of
2 mg/mL arabic gum (Fluka; St. Louis, MO) in H2O was used
as a standard, and the polysaccharide samples were tested at
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incubated for 24 h at room temperature in a humid atmosphere.
Arabinogalactan-positive reactions were identified by a reddish
circle (halo) around the wells.
Fluorescence measurements were performed using an LS50
luminescence spectrometer (Perkin Elmer). Samples were dissolved
in NaHCO3 (25 mM, pH 8.5). Synchronous fluorescence spectra
were recorded from 300 to 600 nm at a scan rate of 240 nm/min.
The excitation–emission wavelength difference (dl) was 20 nm.
Protein content was measured using the Bradford method as per
the manufacturer’s directions (Bio-Rad Protein Assay: Bio-Rad;
Hercules, CA). Bovine serum albumin was used to generate a
standard curve. Absorbance was measured at 595 nm using a
SpectraMax Plus microplate reader (Molecular Devices; Sunnyvale,
CA).
The approximate molecular weight of the Acai-PS fractions was
determined by high performance size exclusion chromatography
(HP-SEC) using a Shimadzu Class VP HPLC and Shodex OHpak
SB-804 HQ column (8 mm6300 mm) as previously described
[41]. The molecular weights were estimated by comparison to the
retention times of pullulan polymer standards (P-800, -400, -200, -
100, -50, -20, and -10; Phenomenex, Torrance CA).
Monosaccharide analysis was performed by the Oklahoma
Center for Glycobiology Analytical Core Lab (Oklahoma City,
OK). Briefly, polysaccharide samples or background blanks were
subjected to methanolysis (methanolic 2 M HCl, 16 h, 80uC),
followed by acid hydrolysis (2 M trifluoroacetic acid, 2 h, 100uC),
and the resulting monosaccharide mixtures were analyzed by high-
performance anion-exchange chromatography with pulsed am-
perometric detection (HPAEC-PAD) on a Dionex DX-600
HPAEC system equipped with an ED50 detector (Dionex
Corporation; Sunnyvale, CA). The samples were separated on a
Dionex CarboPac PA-1 column eluted isocratically with 6 mM or
26 mM NaOH for 30 min, then a 100 mM NaOH gradient for
10 min followed by a sodium acetate gradient from 0 to 500 mM
for 35 min at a flow rate of 1 mL/min at 22uC. For analysis of
Figure 1. cd T cell stimulatory activity in Acai is concentrated in the polysaccharide fraction and effective in all species tested. A)
Aqueous extract of Acai was separated via EtOH precipitation or Kupchan fractionation. The resulting fractions were lyophilized, re-suspended in
water, and tested in bovine PBMC culture for cd T cell agonist activity. Data represent mean and SD from triplicate cultures from the same calf. EtOH
precipitant (ppt.) responses are representative of cultures from three calves and three separate preparations. B) Human cells were cultured for 48 h
with Acai-PS or medium prior to analysis for cell activation (CD69 expression) using flow cytometry. Values represent the average response of
duplicate cultures from a single donor. Data are representative of two experiments. C) CFSE-labeled TCRa
2/2 splenocytes were cultured in X-VIVO
with PBS, Yam-PS (9 mg/mL), or Acai-PS (10 mg/mL) for 24 h, then medium was replaced with fresh medium containing IL-2 and cultured for an
additional 72 h. Percent cell proliferation was determined as the percent of cd T cells (lymphocyte, GL3
+ gates) or others (lymphocyte, GL3- gates)
divided at least once and are representative of two Acai-PS preparations.
doi:10.1371/journal.pone.0017301.g001
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20 min, followed by a gradient of 100 mM NaOH/150 mM
sodium acetate (0–100% for the duration of 45 min). Background
signals were subtracted from all samples, and individual
components were quantified based on electrochemical detection
relative to known standards [42,43].
Carbohydrate content was determined for Acai-PS by phenol-
sulfuric acid method, modified to a microplate format [44], and
absorbance was measured at 490 nm using a SpectraMax Plus
microplate reader. A solution was prepared based on Acai-1 sugar
content as: 4.5% L-rhamnose (Sigma-Aldrich), 47.0% L-(+)-
Arabinose (Sigma-Aldrich), 11.5% D-(+)-galactose (Sigma-Al-
drich), 2.8% D-(+)-xylose (Sigma-Aldrich), 28.4% D-(+)-galacturo-
nic acid (Fluka), and 3.0% D-glucuronic acid (Sigma-Aldrich) by
weight solution in DPBS. This solution was used to generate a
standard curve.
The total amount of polyphenols in the Acai fractions was
determined by Folin-Ciocalteu assay [45] as previously described
[1]. Briefly, 250 mL of Folin’s phenol reagent was added to the
samples dissolved in 500 mL distilled water. After 3 min at room
temperature, 1.25 mL of 20% sodium carbonate was added,
mixed, and the mixture was allowed to stand for 40 min. The
absorbance was measured at 750 nm in a spectrophotometer
(DU800: Beckman Coulter; Brea, CA). The total polyphenol
content was determined using epicatechin to generate a standard
curve and expressed as epicatechin equivalents (epicatechin/mg
sample)6100.
LAL assay was used to estimate the amount of endotoxin
contained in the polysaccharide fractions from Acai. For all
samples tested except the crude acai EtOH precipitation, a
Pyrochrome LAL reagent reconstituted with Glucashield in an
endotoxin-free microplate (all from Associates of Cape Cod; East
Falmouth, MA) as per manufacturer’s procedures was used.
Analyses of endotoxin concentration were performed via the
kinetic method using a VersaMax plate reader with SoftMax Pro
software (Molecular Devices). The crude EtOH-precipitated Acai
was tested for LAL reactivity using the PYROGENT (Cambrex;
Charles City, IA) 0.125 EU/mL sensitivity inverted tube assay. To
calculate the potential endotoxin content in Acai-1, Acai-2, and
Acai-3 a ratio of 8 EU/ng was used.
2.5. Endotoxin removal
To remove potential contaminating endotoxin Acai-1 was
applied to a column containing Detoxi-Gel Endotoxin Removing
Gel (Pierce; St. Louis, MO) and eluted with 0.05 M phosphate
buffer containing 0.5 M NaCl to decrease ionic interactions of
sample molecules with the affinity ligand. The concentration of
polysaccharides in the eluted sample (Acai-1
ER) was adjusted to
match that of the untreated fraction (Acai-1), as determined by
diene group content (absorbance at 254 nm) [46].
2.6. Cell cultures
All cells were cultured at 37uC in a humidified atmosphere
containing 5% CO2. Human monocyte-macrophage MonoMac-6
cells (DSMZ; Brunswick, Germany) were grown in RPMI 1640
(Mediatech Inc.; Herndon, VA) supplemented with 10% (v/v)
FBS, 10 mg/mL bovine insulin, 100 mg/mL streptomycin, and
100 U/mL penicillin.
For primary cells, whole blood was collected from 1–3 month
old bull Holstein calves into sodium heparin tubes (Becton
Dickinson; Franklin Lakes, NJ) or healthy human adult donors
with ACT tubes (Becton Dickinson). Peripheral blood mononu-
clear cells (PBMCs) were separated from whole blood using
Histopaque 1077 (Sigma-Aldrich) for bovine cells as previously
described [47] and human cells, as per the manufacturer’s
instructions. Additionally, bovine red blood cells were removed
by hypotonic lysis. Preparation of spleens from TCRa
2/2 mice for
in vitro culture was performed as previously described [2]. Briefly,
spleens were aseptically removed from the mouse, dounce
homogenized, cold ACK buffer (8.29 g/L NH4Cl, 1 g/L
KHCO3, 292 mg/L EDTA)-treated for 10 min, NitexH filtered,
and density separated using Lympholyte M (Cedarlane Labora-
tories; Burlington, NC) prior to culture at 2.5 E
6/mL in XVIVO-
15 medium (Lonza; Walkersville, MD). Splenocytes were infused
with CFSE, cultured for 24 h with agonists, washed with fresh
medium, and re-cultured for 72 h with medium containing
recombinant murine IL-2 (rmIL-2 [Peprotech; Rocky Hill, NJ]).
2.7. Measurement of cell activation by flow cytometry
Flow cytometry was used to analyze cell activation in bovine,
human, and mouse cultures as previously described [1,3]. To
measure activation, cells were stained with anti-cdTCR monoclo-
nal Ab {GD3.8 (bovine [48]), GL3 (mouse; Becton Dickinson
[49]), or 5A6.E9 (human; ATCC [50])} and either CD69 (human,
FN50; Biolegend, San Diego, CA) or IL-2Ra/CD25 (bovine,
LCTB2A [51]; VMRD, Pullman, WA). For human activation
assays, anti-CD19 (HIB19, Biolegend) and -CD3 (UCHT1,
Biolegend) were also used to identify lymphocyte populations as
follows: abT cells (CD3
+, cdTCR
2), B cells (CD3
2, CD19
+), cdT
cells (CD3
+, cdTCR
+), other cells (CD3
2, CD19
2, cdTCR
2).
To measure mouse splenocyte proliferation in response to rmIL-
2, cells were stained with CFSE prior to culture as described [2]
and then stained with anti- cdTCR mAb (GL-3) after culture. To
differentiate mAb staining, FITC, PE, PE-Cy5.5, or Allophyco-
cyanin (APC) fluorochromes were directly conjugated except for
mAbs 5A6.E9 and LCTB2A, which were detected using
fluorochrome-labeled goat-anti-mouse polyclonal Ab (Southern
Biotech; Birmingham, AL). Indirect Ab staining was blocked using
mouse serum before the addition of other Abs. Cells were analyzed
using a FACSCalibur system equipped with a high-throughput
sampler (Becton Dickinson). Results were analyzed using Cell-
Quest Pro (Becton Dickinson) or FlowJo (Treestar; Ashland, OR)
software.
2.8. Analysis of reactive oxygen species (ROS) production
ROS production was analyzed using the chemiluminescent
probe, L-012, which is highly sensitive for ROS generated in
biologically complex systems [52,53]. Human PBMCs (2610
5 cells
in 100 mL per well) were incubated with various concentrations of
polysaccharide fractions or positive control LPS for 24 h. After
incubation, culture supernatant fluid was replaced with an equal
volume of HBSS supplemented with 25 mM L-012 as described
previously. The reaction was monitored on a Fluoroscan Ascent
FL microtiter plate reader (ThermoElectron; Milford, MA) at
37uC. Chemiluminescence was measured every 2 min for 3 h and
is expressed as the integrated response over this time (arbitrary
units).
2.9. Determination of Acai-induced cytokine production
Cells were incubated for 24 h in culture medium supplemented
with 3% (v/v) endotoxin-free FBS, with or without Acai
polysaccharide fractions or LPS as a positive control. Human
PBMCs and MonoMac-6 human monocytic cells were plated in
96-well plates at a density 2610
5 cells in 100 mL per well. A
human cytokine Multi-Analyte ELISArray
TM Kit (SABiosciences
Corporation; Frederick, MD) was utilized to evaluate various
cytokines {interleukin (IL)-1a, IL-1b, IL-2, IL-4, IL-6, IL-8, IL-10,
IL-12, IL-17A, interferon-c (IFNc), tumor necrosis factor a (TNF-
Ac ¸aı ´ - Polysaccharide-Induced Immune Responses
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CSF)} in supernatants of PBMCs. These results were confirmed
using cells from a different donor with enzyme-linked immuno-
sorbent assay (ELISA) kits for GM-CSF, TNF-a, IL-1b, IL-6, and
IL-8 (all from Biolegend).
Human TNF-a or IL-6 enzyme-linked ELISA kits (Becton
Dickinson and Biolegend) were used to quantify TNF-a or IL-6
levels in the cell supernatant fluids from PBMC or MonoMac-6
cultures.
2.10. Peritonitis assay
BALB/c mice were injected intraperitoneally (i.p.) with 5 mg
Yam-1 [2], 5 mgo r5 0mg of Acai-PS, or saline only. After 4 h, the
mice were euthanized and the peritoneal cavity was washed with
10 mL HBSS (injected and retrieved) and cells collected. The
number of neutrophils was quantified by mAb stain: CD45.2
+
(104, Becton Dickinson), CD11b
+ (M1/70, Becton Dickinson), and
granulocyte receptor-1 (Gr-1;RB6-8C5
bright [54]). A known
concentration of APC-labeled FACSbeads (Becton Dickinson)
was added to these cells prior to flow cytometry using a
FACSCalibur equipped with a high-throughput sampler (Becton
Dickinson). Viable leukocytes were gated based on FSC/SSC and
positive CD45 staining. The absolute count of neutrophils was
calculated based on the number of beads collected versus the
number of viable neutrophils and extrapolated for the 10 mL wash
volume.
2.11. Lung inflammation assay
BALB/c mice (9–10 weeks, female) were instilled intratracheally
(i.t.) with 1.56–500 mg Acai-PS 24 h prior to collection of
bronchoalveolar lavage fluid (BALF) and lung tissue. Prior to
tissue collection, mice were euthanized by CO2 asphyxiation.
BALF was collected by lavage with two 1 mL washes of Hanks
containing 2 mM EDTA. Approximately 1.5 mL lavage fluid was
recovered from each wash. BALF was centrifuged and the
supernatant fluid was saved for IL-12 ELISA (IL-12(p70);
C15.6/C17.8-biotin, MabTech; Nacka Strand, Sweden). The
pelleted BALF cells were treated for 10 min with cold ACK buffer
to lyse red blood cells prior to analysis by flow cytometry. Next,
lung tissue was collected by mincing with scissors then digestion for
1 h in collagenase/DNAse medium {200 U/mL collagenase
(Worthington Biochemical; Lakewood, New Jersey) and 0.08 U/
mL DNAse (Promega; Madison, Wisconsin) in RPMI with 20 mM
HEPES} at 37uC. The resulting product was then passed through
35 mm NitexH nylon mesh (Sefar America; Depew, NY) to remove
tissue debris and ACK lysed. To analyze the cellular composition
of the tissue and BALF, cells were stained with CD11b-FITC
(M1/70; Becton Dickinson) and CD11c-APC (HL3; Becton
Dickinson) prior to analysis using a FACS Calibur cytometer
(Becton Dickinson).
2.12. Statistics
Statistical analyses were performed using Microsoft Excel or
GraphPad Prism.
Results
Acai polysaccharides trigger minimal response in LAL
detection assays and are potent agonists for bovine,
human and mouse cd T cells
In preliminary assays culturing peripheral PBMCs with crude
Acai, we identified cd T cell activation (up-regulation of CD69/
IL-2Ra expression). This activity was independent of prenyl
phosphates since bovine cd T cells responded to this extract,
suggesting the agonist activity could be due to polyphenols and/or
polysaccharides [data not shown]. As a first step toward
identification of the activating component(s) of the Acai extract,
we separated the crude extract via Kupchan fractionation [39] or
EtOH precipitation. Dose response assays were performed on the
various fractions by measuring bovine cd T cells activation in
PBMC cultures. As shown in Figure 1A, EtOH-precipitated
material induced cd T cell activation as measured by IL-2Ra
expression at low ng/mL concentrations. Furthermore, no activity
was detected in the EtOH-soluble or non-polar fractions. Since
polysaccharides precipitate in EtOH, whereas polyphenols, in
general, remain soluble in ethanol, this suggested that polysac-
charides were the agonist fraction in Acai. We next compared
LAL reactivity in the EtOH-precipitated Acai to Yamoa
TM-
derived polysaccharides (Yam-1) which are described in a previous
report.
2 EtOH-precipitated Acai had far less potential endotoxin
reactivity than Yam-1 (.0.0000125 EU/ng for Acai versus
0.194 EU/ng for Yam-1). These experiments indicated that Acai
polysaccharides activate cd T cell populations without the
potential endotoxin contamination or LAL cross-reactivity com-
mon to Yamoa
TM and other polysaccharides.
To determine if Acai polysaccharides similarly activated mouse
and human cells, we further purified the polysaccharides from
EtOH-precipitated Acai using DEAE cellulose. This fraction,
Acai-PS, was 92.1% polysaccharides as determined by phenol-
sulfuric acid assay, and as expected, retained low LAL reactivity
(0.0004 EU/ng). As shown in Figure 1B, Acai-PS increased the
expression of CD69 on human lymphocytes, with the most robust
activity detected in cd T cells. Other cell populations including B
cells and the unstained gate (other cells; presumably CD3
dim T
cells, CD19
dim B cells, NK cells, and/or small monocytes)
demonstrated increased CD69 expression to some degree. Mouse
cd T cells also responded to the Acai-PS fraction, as demonstrated
by increased proliferation in response to rmIL-2 (Figure 1C). This
in vitro priming response was repeated in TLR2
2/2 and wildtype
mice (C57BL/6). Importantly, we observed no toxic effects from
Acai in vitro at concentrations up to 500 mg/mL [human PBMCs,
data not shown] indicating these observed cd T cell responses were
not a result of cellular distress.
cd T cell agonist activity in Acai was found in the
polysaccharide and not the polyphenol fraction
Since earlier reports demonstrated immunomodulatory activity
of Acai polyphenols [34–36] and we have found that some
polyphenols are potent cd T cell agonists [1,3], we purified
polyphenols from Acai and tested them for activity. As shown in
Figure 2A, purified Acai polyphenols did not increase CD69
expression on cd T cells at dosages nearly ten times higher than
the polyphenol agonist, Apple Polyphenol (APP) [1]. Also, there
was no shift in the dose response curve of Acai-PS in which
polyphenols were removed (Acai-PS
PR) by PVPP pre-treatment
(Figure 2B). These results indicate that the previous reports
describing polyphenol-induced immune responses were not a
result of activated cd T cells.
To better characterize the Acai polysaccharide agonist, the
Acai-PS extract was then fractionated by preparative Sepharose
6B size-exclusion chromatography to obtain three fractions, which
were selected based on the total carbohydrate elution profile
(designated as: Acai-1, Acai-2, and Acai-3, Figure 3A). Based on
calibration curves derived from pullulan standards [41], we
determined that fraction Acai-1 was composed of molecules with
mass ,200,000 Da as well as a small sub-peak at ,800,000 Da,
which could represent molecular aggregates. Acai-2 had a broad
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at 4,000–12,000 Da (Table 1). As expected, all of these fractions
remained low in LAL reactivity (Table 1). The fractions were then
analyzed for polysaccharide and protein content and found to
contain .99% carbohydrate and ,1.0% protein (Table 1). Note
that the carbohydrate profile was in accord with that of refractive
index chromatogram obtained by HP-SEC (Figure 3B).
All three fractions exhibited fluorescence emission in the broad
region of 370–540 nm (Figure 3C). This finding suggested the
presence of aromatic groups in context of the polysaccharides;
however, this method will detect minute levels of aromatic groups,
therefore the relative contribution of aromatics could not be
estimated from this assay. To estimate potential aromatics, we
performed a Folin-Ciocalteu assay. Results indicated polyphenols
were a trivial component of the Acai-1 fraction (0.2%) and a minor
component of the Acai-2 and Acai-3 fractions, 2.8% and 5.9%,
respectively (Table 1). This result further demonstrated that the
polysaccharide and not the polyphenol fraction was the predom-
inant source of cd T cell activity in the Acai preparation.
Very-high-field (600 MHz)
1H NMR was used to characterize
the structure of the native Acai polysaccharides. The spectra from
all three fractions (Figure S1) suggested a backbone structure
resembling native arabinogalactans isolated from various plant
Figure 2. Acai fruit does not contain polyphenol-based cd T cell
agonists. A) PVPP-extracted Acai polyphenols were cultured with
human PBMCs to detect cd T cell activation. As a control, APP [1] was
used to induce polyphenol-based cd T cell activation. B) Acai-PS was
treated with PVPP to remove polyphenols and the resulting preparation
(Acai–PS
PR) or untreated Acai-PS was cultured with human PBMCs. cd T
cell activation from the subsequent cultures was measured by FACS as
induced CD69 expression. Results are from three individual donors.
Error bars represent SD. Experiments were performed independently
with respect to donor, experiment date, and Acai-PS
PR extraction.
doi:10.1371/journal.pone.0017301.g002
Figure 3. Chromatographic characterization and fractionation
of Acai polysaccharides. Water extract of Acai was prepared and
separated on DEAE-cellulose column (Acai-PS) and quantified using
multiple methods: A) Acai-PS fractionation by gel chromatography on
Sepharose-6B column. Three polysaccharide fractions (designated Acai-
1, Acai-2, and Acai-3) were selected based on total carbohydrate and
diene conjugate contents. B) High pressure gel filtration chromatogra-
phy elution profile of Acai-PS with a refractive index detector. C)
Synchronous fluorescence spectra of polysaccharides isolated from
Acai-PS{500 mg/ml of each polysaccharide fraction in NaHCO3 buffer
(pH 8.5)}.
doi:10.1371/journal.pone.0017301.g003
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for the sugar composition of the arabino-3,6-galactans (type II)
[55,56], we identified the presence of unsaturated a-rhamnopyr-
anose, b-galactopyranose, a-arabinofuranose, and a-galacturono-
pyranose. All spectra also indicated a significant amount of N- and
O-acetyl (1.9–2.0 ppm), methyl (0.75 and 1.1 ppm), and alkyla-
mide (3.21 ppm) groups.
Type II arabinogalactan contains a b-(1,3)-linked galactan
backbone with side chains containing arabinose and galactose
residues and has reported biological activities in other systems
[57,58], but importantly, polysaccharide fractions containing type
II arabinogalactan also contain the most activity as cd T cell
agonists [2,41 and unpublished results]. To evaluate the Acai
polysaccharide fractions for arabinogalactan, the Yariv test was
performed. All three fractions resulted in a positive reaction,
indicating they contained arabinogalactan type II (Table 1). Sugar
composition analysis revealed that the Acai polysaccharides
consisted primarily of arabinose, galacturonic acid, and galactose
(Table 2) which supports the results of the Yariv test and the
presence of arabinogalactans in these fractions.
These results indicated that the Acai polysaccharide fractions
Acai-1, Acai-2, Acai-3 contain different structures as determined
by size, sugar content, and NMR. Furthermore, these fractions
were predominantly polysaccharide with very low polyphenol or
protein content.
Acai polysaccharides induce cd T cell and myeloid cell
activation
The activity of the Acai-PS fractions was tested using the CD69
expression assay for human PBMC cultures. As shown in
Figure 4A, treatment with Acai-1 and to a lesser extent Acai-2
activated human cd T cells with minimal activity on ab T cells and
B cells. We also tested the monomeric sugars from Acai-1. These
sugars had no agonist effect [data not shown], indicating the
complex structure of Acai-PS is important to its immune activity.
Since other polysaccharide preparations are potent inducers of
reactive oxygen species (ROS) formation [41], we tested Acai
polysaccharides for similar responses. In the absence of any
treatment, human PBMCs did not generate detectable ROS
(Figure 4B, control), whereas the addition of Acai-PS fractions
activated ROS production with a lag-phase of around 30 min. A
concentration-dependent enhancement of ROS production was
observed in PBMCs treated with 37.5–300 mg/mL of each
polysaccharide fraction (Figure 4C). As in the cd T cell activation
assays, Acai-1 demonstrated the most activity.
We next examined cytokine production by Acai-treated human
PBMCs. Among the twelve cytokines analyzed, six were
consistently induced in PBMCs by 100 mg/mL of Acai polysac-
charide fractions, as compared with control cells. For Acai-1, these
included IL-1a {fold increase (FI)=4.8}, IL-1b (FI=15.9), IL-6
(FI=223), IL-10 (FI=57), TNF-a (FI=23), GM-CSF (FI=4.2)
(Figure 4D).
The ROS formation and cytokine secretion profile indicated
that Acai polysaccharides function similarly to polysaccharide
preparations active on monocytes [2,41]. Therefore, we further
analyzed the monocyte response to Acai polysaccharides.
Although the amount of endotoxin (LPS) was very low and far
larger amounts are required to activate cd T cells [2,59],
monocytes are exquisitely sensitive to endotoxin. Thus, further
steps were taken to ensure that endotoxin was not a component of
the Acai preparation. To this end, we prepared a detoxified Acai-1
by elution through a column of endotoxin-removing gel (denoted
Acai-1
ER). To quantify dose-dependent effects of Acai polysac-
charides on monocyte-associated cytokine production, levels of
TNF-a and IL-6 were determined in cells treated with the
polysaccharide fractions by ELISA. As shown in Figure 5,
incubation of PBMCs with the fractions enhanced TNF-a and
IL-6 production in a dose-dependent manner. Acai-1 and Acai-
1
ER induced very similar responses indicating the minor endotoxin
contamination had no effect on the activity of Acai-1. Further-
more, as with previous experiments, the Acai-1 fractions were the
most active fraction at low concentrations (,1 mg/mL). Although
a slight decrease in TNF-a production in Acai-1-treated cultures
from 5 to 10 mg/mL was noted, the level of the cytokine was
increased when cells were exposed to a higher dose (100 mg/mL)
of Acai-1. We hypothesized this was due to the inherent
heterogeneous nature of cell populations in PBMC cell prepara-
tions and their differing responses to the polysaccharides.
Table 1. Biochemical and spectral properties of Acai polysaccharide fractions.
Polysaccharide fraction
Average molecular
weight (kDa)
Potential endotoxin
(ng/mg)
Protein content
(w/w)
Total phenolic
content (w/w) Type II arabinogalactan
Acai-1 200 0.33 0.35% 0.2% Positive
Acai-2 26–60 0.05 0.43% 2.8% Positive
Acai-3 4–12 0.01 0.60% 5.9% Positive
doi:10.1371/journal.pone.0017301.t001
Table 2. Monosaccharide composition of Acai polysaccharide
fractions.
Polysaccharide fraction
Monosaccharide Acai-1 Acai-2 Acai-3
Fucose 0.5 0.6 1.3
Rhamnose 4.5 4.1 4.9
Arabinose 47.0 26.2 18.8
Glucosamine N.D. N.D. N.D.
Galactose 11.5 17.9 16.5
Glucose 2.3 10.4 18.8
Lyxose N.D. N.D. N.D.
Mannose N.D. 4.7 8.4
Xylose 2.8 9.7 8.0
Galacturonic acid 28.4 24.7 21.7
Glucuronic acid 3.0 1.8 1.5
The data are present as mol% for each sugar. Individual components were
identified and quantified based on elution of known standards. N.D. – not
detected.
doi:10.1371/journal.pone.0017301.t002
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rides, we tested the fractions on a human monocyte cell line,
MonoMac-6. As with the PBMC cultures, Acai-1
ER induced
nearly identical responses to the non-endotoxin-cleared Acai-1 in
MonoMac-6 cells (Figure 5). MonoMac-6 cells also responded
similarly to human PBMCs (Figure 5) without the cytokine
secretion plateau, confirming that monocytes respond in a dose-
dependent manner to Acai polysaccharides. The elimination of the
cytokine secretion plateau and the greatly reduced TNF-a
production in the MonoMac-6 cultures indicated monocytes were
not the sole responding factor to Acai polysaccharides. These
results, in combination with the activation of cd T cells, were
consistent with our earlier studies on Yamoa that indicate cd T
cells, monocytes, and possibly other cells cooperate for innate
responses induced by polysaccharides [2].
Acai polysaccharides induce immune recruitment and
activation responses in vivo
Since Acai polysaccharides affect multiple cell types, we next
sought to examine the combined effects of Acai-derived polysac-
charides in vivo. To this end, we first examined their effect on the
recruitment of neutrophils after intraperitoneal (i.p.) injection in
mice. As shown in Figure 6A, Acai-PS induced neutrophil
recruitment into the peritoneum, similar to LAL
+ polysaccharides,
Yam-1. Consistent with our previous report demonstrating a clear
difference between Yam-1- and LPS-induced responses [2], the
effect was not contingent upon MyD88 signaling (Figure 6B). Since
MyD88
2/2 mice are documented to possess an atypical immune
response [60,61], no conclusions can be reliably drawn from the
apparent reduction of peritonitis in MyD88
2/2 mice versus wild-
type mice; it may be that there is a MyD88-dependent component
to the full response or it may be due to strain differences. These
results indicate that the in vitro immunostimulatory responses we
observed toward Acai polysaccharides were preserved in vivo.
To determine if Acai-derived polysaccharides induce immune
responses at mucosal surfaces, mice were treated i.t. with 500 mg
Acai-PS and, 24 hrs later, cells in the BALF and lung tissue were
extracted to measure myeloid cell activation/recruitment. In the
BALF, alveolar macrophages (autofluorescent, Oval gate) in-
creased expression of CD11c (Figure 7A), indicating these resident
cells were activated. Similar to the peritonitis experiments, there
was also a neutrophil influx detected in the BALF as shown by the
increased CD11b
+/CD11c
2 population (Figure 7A). These cells
were likely neutrophils because of their high Gr-1 expression and
distinctive light scatter profiles [data not shown]. The remaining
lung tissue was then homogenized and collagenase digested to
Figure 5. Effect of Acai polysaccharide on TNF-a and IL-6 production in MonoMac-6 and human PBMCs. Human PBMCs or MonoMac-6
macrophages were incubated for 24 h with the indicated concentrations of polysaccharide fractions Acai-1, Acai-1 pretreated with endotoxin-
removing gel (Acai-1
ER), Acai-2, Acai-3, or 200 ng/mL LPS. Cell-free supernatants were collected, and extracellular TNF-a and IL-6 were quantified by
ELISA. Values represent the mean 6 SD of triplicate samples from one experiment, which is representative of at least three independent experiments.
doi:10.1371/journal.pone.0017301.g005
Figure 4. Acai fractions induce cell activation, as well as, ROS and cytokine production. A) PBMCs were collected from three donors and
cultured with indicated agonists at various concentrations (x axis). Cultures were performed in triplicate. Data represent the mean fold increase (CD69
mean fluorescence) versus medium for each agonist/concentration value. Error bars represent normalized SD. B) PBMCs were incubated with
polysaccharide fractions (150 mg/mL) and ROS production was measured over 300 min. C) ROS production from PBMCs was measured as a function
of dose. PBMCs were incubated with the indicated concentrations of polysaccharide fractions, LPS, or vehicle only for 24 h. ROS production was then
measured for 3 h from triplicate samples. Data represent the mean 6 SD total luminescence over 3 h. Values are from one experiment, representative
of three independent experiments. D). An ELISA was used to measure cytokine production by human PBMCs treated with 50 mg Acai-PS. Values
represent the mean fold increase versus medium control cultures from triplicate wells. Error bars represent SD. Cultures were from one subject.
Production of IL-1b, IL-6, GM-CSF, and TNF-a, and as well as limited IL-8 was confirmed in PBMCs from at least one additional donor using different
ELISA reagents.
doi:10.1371/journal.pone.0017301.g004
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additional CD11b/CD11c positive cell population (Figure 7B,
rectangles). It is unknown from these experiments whether these
additional myeloid cells were recruited or whether they were
activated resident cells. Regardless of the source of these activated
myeloid cells, these experiments demonstrate a change in lung
innate immune cell profile upon Acai administration.
To further characterize the lung response to Acai, the BALF was
tested for the proinflammatory cytokine, IL-12. In initial studies
from four mouse strains (BALB/c, C57BL/6, C3H/HeJ, and
MyD88
2/2) we observed an increased IL-12 content in Acai-PS-
treated versus control animals [n$2 for each strain, data not
shown]. Therefore, to estimate the dose response, BALB/c mice
were treated i.t. with a range of Acai-PS doses, and the
concentration of IL-12 in the BALF was measured. As shown in
Figure 7C, Acai-PS dose-dependently induced IL-12 production
within the lung, indicating a proinflammatory TH1 response. Thus,
the myeloid cell-associated response to Acai polysaccharides was
conserved in both lung and peritoneal tissues. In contrast to the
current thought that Acai polyphenols are responsible for immune
enhancement [35,36,62], these data demonstrate immunostimula-
tory properties of Acai polysaccharides both in vitro and in vivo.
Discussion
Although Acai is heavily marketed and currently taken by the
general public to enhance immune cell function (presumably
through antioxidant function), for weight loss, and for a variety of
other unfounded claims, there have been few studies on its specific
mechanisms of action. Indeed, much of the information justifying
its use is anecdotal. Herein, we show that polysaccharides, but not
polyphenols, derived from Acai fruit pulp have potent immuno-
modulatory activity and stimulated both cd T cells and myeloid
cells. The in vitro response to Acai-PS was conserved between
mouse, bovine, and human cells and correlated with in vivo
responses. In mice, Acai-PS incited neutrophil recruitment to the
peritoneum and lung as well as activated DCs/macrophages in the
lung. This peritonitis response occurred independent of MyD88
signaling, though at a lower level. This latter result, in
combination with the minimal LAL reactivity, shows that
bacterial-derived endotoxin is likely not responsible for the activity
of Acai-derived polysaccharides and that these polysaccharides
contain a distinct innate immune agonist.
The limited analyses reported to date suggest that polyphenols
represent the immunomodulatory compounds in Acai [34,35,37,38].
In contrast, the activity reported here tracked solely to the
polysaccharide fraction of the Acai fruit pulp, and we found little to
no activity from the polyphenols within this extract. Evidence against
polyphenol-induced cd T cell activation was based on: 1) an absence
of immune cell activity in polyphenols purified from Acai-extract
(Figure 2A), 2) a retained bioactivity in Acai preparations depleted of
polyphenols (Figure 2B), and 3) the limited amounts of polyphenols in
the purified Acai-fractions (Table 1). It is unlikely that the very small
amounts of free polyphenols not removed by PVPP could account for
our results, since a defining characteristic of cd Tc e l li m m u n o m o d -
ulatory polyphenols is the relatively high concentrations (low mg/mL)
required to induce cellular responses in vitro [1,3]. It remains possible
that polyphenol-complexed polysaccharides are required for biolog-
ical activity since there was a small amount of polyphenols in the
Acai-1, Acai-2 and Acai-3 fractions. However, the most active
fraction, Acai-1, had the least amount of polyphenol (0.2%, Table 2),
rendering this theory unlikely. It is therefore likely that the previous
reports describing polyphenol activity were a result of general
antioxidant effects. This is not unexpected since Acai has a very high
antioxidant capacity [36,63].
The fractions tested herein were derived from the Acai fruit
pulp since it is the primary source of nutritional supplements and
foodstuffs. The fruit pulp contains a relatively low concentration of
the preeminent cd T cell polyphenol agonist, OPC [62,63], which
could explain the lack of cd T cell agonist activity. However, the
seed from Acai fruit contains an enriched OPC profile very similar
to APP or grape seed [38]. Since OPCs from APP, grape seed, and
others activate cd T cells [1,3,64], polyphenols extracted from
Figure 6. Acai polysaccharides induce MyD88-independent
neutrophil influx to the peritoneum. A) BALB/c mice were injected
intraperitoneally with saline, Acai, or Yam-1. After 4 h, mice were
euthanized, peritoneal cells collected, and total neutrophil counts
measured by flow cytometry. Data represent the average total cell
count from a minimum of four mice per treatment group and error bars
represent the SEM. B) C57BL/6 or MyD88
2/2 mice of mixed ages (12–23
weeks) and sexes were injected i.p with Acai-PS (400 mg) or saline and
neutrophil flux was measured as in A) without the use of FACS beads to
estimate total cell counts. The data are representative of the mean
percentage of neutrophils in the wash 6 SD from a single experiment
with 3–4 mice/group. p-values (Student’s T test) for both figures are
represented as: *,0.05, **,0.01, ***,0.005, ****,0.001.
doi:10.1371/journal.pone.0017301.g006
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the potential cd T cell agonist activity of the polyphenol extract
from Acai seed was beyond the scope of these studies, additional
studies are underway to determine its biological activity. If it holds
true that Acai seed polyphenols contain cd T cell agonist activity,
the seed could be prepared as a distinct nutritional supplement.
Acai seeds are currently a byproduct of the Acai fruit, and are
generally wasted or being used as pig feed or potting soil [38]. This
seed may be an alternative and economically feasible source for cd
T cell-activating polyphenols for human applications.
Questions have been raised about the role of microbial
contaminants in plant-derived products contributing to immuno-
modulatory activity [65,66], thereby necessitating strict control over
potential contaminants. Furthermore, products such as polysaccha-
rides are particularly difficult to control for since they can cause
false-positive LAL reactions [67,68] and are difficult to isolate from
endotoxin using conventional methods [2]. We found no evidence
of microbial contamination in the Acai extract, as evidenced by
minimal LAL reactivity and negative results of attempted bacterial
culture [data not shown]. Furthermore, the bioactivity in Acai-1
Figure 7. Intratracheal (i.t.) treatment with Acai-PS activates lung myeloid cells and induces IL-12 production in mice. BALB/c mice
(n=3) were treated i.t. with vehicle (dH20) or 500 mg Acai-PS in a volume of 100 mL. BALF and lung cells were isolated 24 h post-treatment. Cells were
stained with antibodies for CD11b and CD11c and analyzed via flow cytometry for myeloid cell activation/recruitment. A) BALF alveolar macrophages
were gated (autofluorescent/CD11c
+; ovals) and activation was measured as an increase in mean CD11c-associated fluorescence within this gate. B)
Cells in the lung interstitium were collected via collagenase extraction and similarly analyzed by FACS for myeloid cell recruitment/activation. The
percentage of myeloid cells (rectangle gate) in relation to total live leukocytes was compared between Acai-PS and vehicle treated mice. Data from A)
and B) are representative of three similar experiments and were repeated in C57BL/6 (3 experiments) and C3H/HeOuJ (2 experiments). C) BALF was
collected from BALB/c mice provided varying dosages of Acai-PS i.t. Cells were removed by centrifugation, and IL-12(p70) concentration was
determined in the supernatant fluid by cytokine ELISA.
doi:10.1371/journal.pone.0017301.g007
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occurred inanimalsdeficientinMyD88signaling(Figure6B).Thus,
sensing of microbial products through TLRs likely does not account
for the innate cell responses shown in this report. However, it could
very well be that MyD88-independent, yet TLR-dependent,
pathways, such as TLR4-mediated TRIF signaling, are involved
in recognition of the polysaccharides and these issues are currently
under study. Furthermore, elaboration of processed IL-1b suggests
that Acai polysaccharides could affect the inflammasome, for which
agonists are highly variable [69,70]. This possibility clearly
warrants, and is under, further investigation.
To date, we have defined myeloid cell agonist activity in a
number of plant extracts, including extracts from juniper berries
[41], Artemisia [40], prickly-pear cactus [71], Yamoa
TM [2], and
now Acai. Activity on cd T cells has also been observed with these
extracts, excluding cactus [2, this report, and unpublished results].
Thus, the relevant cd T cell agonists may be polysaccharides
common to many plants. As such, we predict that other plants
contain bioactivity similar to that in Acai, which may account for
the expansion of cd T cells in people that have consumed certain
fruit and vegetable extracts [31].
As discussed in Graff et al., Yamoa
TM is purported to be beneficial
in asthma [2]. Asthma is associated with an exaggerated TH2
cytokine response mediated in part by cd T cells. In mice, lung cd T
cells are present that can either promote or restrict TH2c y t o k i n e
responses [72]. Clinical evidence indicates that cd T cells are
increased [73] in asthmatic patients and also that these cells produce
large amounts of TH2 cytokines after antigen challenge [74]. Since
therapies to increase TH1 responses can alleviate asthma symptoms
[75], we originally proposed that the anecdotal asthma benefits
attributed to plant polysaccharides, might be a result of tipping the cd
T cell cytokine balance in the lung towards a TH1r e s p o n s e .A tt h e
time, we had no direct evidence in support of this hypothesis, and
results would have been difficult to interpret due to the endotoxin-
reactive component of Yamoa polysaccharides. Here we found that
Acai-1 directly induced IL-12 production in the mouse lung. IL-12
release favors a downstream TH1r e s p o n s ev i aI F N - c production
from leukocytes in the mucosa [76]. Thus, we provide, for the first
time, mechanistic evidence for the potential benefit of some plant
polysaccharides by driving TH1 responses in the lung. In addition,
IFN-c is crucial for host defense responses against intracellular
bacterial pathogens of the lung, such as Francisella tularensis [77] and
Coxiella burnetii [78]. Efforts are currently underway to test the
effectiveness of Acai polysaccharides in countering lung infections in
these and a variety of other pulmonary infection models.
Another issue currently under investigation is whether the plant
polysaccharide-induced immune cell activity can also be produced
following oral ingestion. There are many variables within these
experiments such as the effects of gastric enzymes, low pH, normal
bacterial flora, and agonists in a normal diet on the agonist activity.
However, Acai polysaccharide extracts are certainly resistant to harsh
chemical conditions similar to the stomach, including high heat
(boiling; see preparation in materials and methods) and low pH (1 M
HCl; data not shown). To date, it is uncertain whether Acai
polysaccharides translocate across epithelial barriers; however, there
is precedence for modulation of systemic immune activity by
consumption of plant- and microbial-derived glucans [79] as well
as large polysaccharide polymers from Aureobasidium pullulans [80] and
Ganoderma lucidum [81,82]. Furthermore, immunomodulatory poly-
saccharides can impact intestinal leukocytes and enterocytes [83]. In
the event that the polysaccharides described herein are restricted to
acting upon cells within the intestine, intraepithelial cd T cells could
still be targeted. Potential therapeutic applications for a gut-restricted
cd T cell agonist include epithelial healing [24,25] and improved
immune responses to a variety of pathogen-associated diseases [16].
In preliminarystudies,somemice administered Acai-PSor Yam-1 by
oral gavage produced a cytokine response that could be detected
within the serum [unpublished observations]. Therefore, it would
seem that Acai polysaccharides are capable of inducing a systemic
immune response. These preliminary results are being investigated in
detail as part of ongoing studies to determine the in vivo and
therapeutic potential for cd T cell-agonist polysaccharides.
In closing, characterization of the immune responses or lack
thereof for common nutritional supplements is important for
potentially isolating new drug candidates but also for preventing
potential misuse by the public. Herein, we define potent immuno-
modulatory activity from Acai on monocyte and cd Tc e l l
populations. Unlike previous reports describing activity in the
polyphenol fraction, we instead identified activity in the polysaccha-
ride fraction. These polysaccharides were able to induce cell
recruitment and TH1 responses in vivo. As such, potential applications
for these polysaccharides include asthma and infectious disease. The
absence of significant LAL reactivity is critical for the description of
polysaccharide-induced immune responses in vivo and provides a
readily available source for the development of a clinical preparation.
Supporting Information
Figure S1
1H NMR spectra of Acai-PS fractions. The
fractions were dissolved in D2O, and spectra were recorded at
20uC, as described [41]. Using previously described methods, we
predict the following peak associations which are marked on the
Acai-3 graph: weak signals present at 3.37–3.45 ppm represent a-
rhamnopyranose (a-Rha p), the strong signals at 3.54–3.96 ppm
represent b-galactopyranose (b-Gal p) [84], and the signals at
4.04–5.07 ppm represent a-arabinofuranose (a-Ara f) as well as a-
galacturonopyranose (a-GalA p) residues [56,84]. N- and O-acetyl
(1.9–2.0 ppm), methyl (0.75 and 1.1 ppm), and alkylamide
(3.21 ppm) groups are also represented.
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